Skip to content

Clinical trials

Completed Phase 2 Vascular Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vascular Diseases Phase: Phase 2 Status: Completed Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20031
20041
20052
20071
20081
20093
20111
20122
20133
20142
20151
20161
20172
20182
20193
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)8
Neuroscience Trials Australia3
Duke University2
Emory University2
Takeda2
University of Minnesota2
Abbott Medical Devices1
Akcea Therapeutics1
AnGes USA, Inc.1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vascular Diseases42
Cardiovascular Diseases25
Heart Diseases16
Hypertension10
Cerebrovascular Disorders6
Central Nervous System Diseases5
Peripheral Arterial Disease5
Stroke5
Arterial Occlusive Diseases4
Atherosclerosis4

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.